Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Single-Agent LY2780301 in Patients With Advanced or Metastatic Cancer

NCT01115751 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01115751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01115751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Single-Agent LY2780301 in Patients With Advanced or Metastatic Cancer
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2010
Completion date
July 31, 2012
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastases, neoplasm